Letters
Drug company influence
COPD: inhalers distract from exercise and clean air
BMJ 2019; 365 doi: https://doi.org/10.1136/bmj.l2156 (Published 17 May 2019) Cite this as: BMJ 2019;365:l2156
- Nicholas Sharvill, general practitioner
- Deal, UK
- john.sharvill{at}nhs.net
Salisbury says that Boehringer Ingelheim is paying £748 000 (€868 000; $973 000) towards an integrated multidisciplinary respiratory team in Oxford, compared with £181 000 from the clinical commissioning group (CCG).1 I hope the CCG finance and …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.